Company name
2022Founder
Giovanni Carosso develops programmable biological modalities and drug-discovery platforms as a member of technical staff at Capable. He previously led research at General Control and worked on the GEMS platform at Epicrispr Biotechnologies.
MTS, Therapeutic Development
Founding Head of Research
Postdoctoral Scholar, Neurological Surgery
Researcher, Neurogenetics
PhD, Human Genetics
BS, Biopsychology